Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Veronique T Baron"'
Autor:
Gaelle Rondeau, Parisa Abedinpour, Prerak Desai, Veronique T Baron, Per Borgstrom, John Welsh
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e101160 (2014)
In metastasis, circulating tumor cells penetrate the walls of blood vessels and enter the metastatic target tissue, thereby becoming exposed to novel and relatively unsupportive microenvironments. In the new microenvironments, the tumor cells often r
Externí odkaz:
https://doaj.org/article/7602efcb5e3343c09867ef6b1a93aee0
Autor:
Rebecca Pio, Zhenyu Jia, Veronique T Baron, Dan Mercola, UCI NCI SPECS Consortium of the Strategic Partners for the Evaluation of Cancer Signatures-Prostate Cancer
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e54096 (2013)
Members of the early growth response (EGR) family of transcription factors play diverse functions in response to many cellular stimuli, including growth, stress, and inflammation. Egr3 has gone relatively unstudied, but here through use of the SPECS
Externí odkaz:
https://doaj.org/article/a3f8625643d04218b0a5dfe1e53dff7a
Publikováno v:
BioMed Research International, Vol 2022 (2022)
BioMed Research International
BioMed Research International
Plumbagin, a bioactive naphthoquinone, has demonstrated potent antitumor potential. However, plumbagin is a sparingly water-soluble compound; therefore, clinical translation requires and will be facilitated by the development of a new pharmaceutical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88822e535ee46fd2fd914037146d333b
https://doi.org/10.1155/2022/3549061
https://doi.org/10.1155/2022/3549061
Publikováno v:
Cancer Research. 83:6111-6111
Poly(ADP-ribose) polymerase (PARP) inhibitors are currently used in the clinic for the treatment of tumors with a defective DNA damage response (DDR). When PARP1 or PARP2 binds damaged DNA, it adds poly(ADP-ribose) chains to its own backbone and to o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9deaa9e7534c11b712f9786979dc6b8b
https://doi.org/10.1158/1538-7445.am2023-6111
https://doi.org/10.1158/1538-7445.am2023-6111
Publikováno v:
PLoS ONE
Pio, R; Jia, Z; Baron, VT; & Mercola, D. (2013). Early Growth Response 3 (Egr3) Is Highly Over-Expressed in Non-Relapsing Prostate Cancer but Not in Relapsing Prostate Cancer. PLoS ONE, 8(1). doi: 10.1371/journal.pone.0054096. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/2p20j09n
Pio, Rebecca; Jia, Zhenyu; Baron, Veronique T; Mercola, Dan; & Agoulnik, Irina U. (2013). Early Growth Response 3 (Egr3) Is Highly Over-Expressed in Non-Relapsing Prostate Cancer but Not in Relapsing Prostate Cancer. PLoS ONE, 8(1), e54096. doi: 10.1371/journal.pone.0054096. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/68c8c89r
PLoS ONE, Vol 8, Iss 1, p e54096 (2013)
Pio, R; Jia, Z; Baron, VT; & Mercola, D. (2013). Early Growth Response 3 (Egr3) Is Highly Over-Expressed in Non-Relapsing Prostate Cancer but Not in Relapsing Prostate Cancer. PLoS ONE, 8(1). doi: 10.1371/journal.pone.0054096. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/2p20j09n
Pio, Rebecca; Jia, Zhenyu; Baron, Veronique T; Mercola, Dan; & Agoulnik, Irina U. (2013). Early Growth Response 3 (Egr3) Is Highly Over-Expressed in Non-Relapsing Prostate Cancer but Not in Relapsing Prostate Cancer. PLoS ONE, 8(1), e54096. doi: 10.1371/journal.pone.0054096. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/68c8c89r
PLoS ONE, Vol 8, Iss 1, p e54096 (2013)
Members of the early growth response (EGR) family of transcription factors play diverse functions in response to many cellular stimuli, including growth, stress, and inflammation. Egr3 has gone relatively unstudied, but here through use of the SPECS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e204f456087f85969bb29b45d85d6f85
https://pubmed.ncbi.nlm.nih.gov/23342084
https://pubmed.ncbi.nlm.nih.gov/23342084